fda bpc-157 not approved for human use warning panel backs easier access to peptides The Unregulated World of Peptides:

Aberrant modification patterns, often resulting from enzymatic dysfunction, are linked to neurological pathologies, oncogenesis, and metabolic disorders [24,25,26]

Researchers working with lyophilised peptide compounds frequently incorporate bacteriostatic water as part of reconstitution protocols within peptide laboratory applications and compound stability assessments conducted under appropriate in-vitro research environments

The FDA says that they would not take action against a compounder for using a Category 1 substance but would consider taking action for those that use Category 2 or 3 substances

Position on lipotropic injections: The NHS does not endorse lipotropic injections for weight management or metabolic enhancement